111 related articles for article (PubMed ID: 16508195)
1. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
[TBL] [Abstract][Full Text] [Related]
2. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors.
Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T
J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925
[TBL] [Abstract][Full Text] [Related]
3. Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity.
Chen S; Zhao X; Tan J; Lu H; Qi Z; Huang Q; Zeng X; Zhang M; Jiang S; Jiang H; Yu L
Eur J Pharmacol; 2007 Jun; 565(1-3):54-9. PubMed ID: 17449029
[TBL] [Abstract][Full Text] [Related]
4. FRET-Protease-Coupled Peptidyl-Prolyl cis-trans Isomerase Assay: New Internally Quenched Fluorogenic Substrates for High-Throughput Screening.
Caporale A; Mascanzoni F; Farina B; Sturlese M; Di Sorbo G; Fattorusso R; Ruvo M; Doti N
J Biomol Screen; 2016 Aug; 21(7):701-12. PubMed ID: 27185744
[TBL] [Abstract][Full Text] [Related]
5. One novel quinoxaline derivative as a potent human cyclophilin A inhibitor shows highly inhibitory activity against mouse spleen cell proliferation.
Li J; Chen J; Zhang L; Wang F; Gui C; Zhang L; Qin Y; Xu Q; Liu H; Nan F; Shen J; Bai D; Chen K; Shen X; Jiang H
Bioorg Med Chem; 2006 Aug; 14(16):5527-34. PubMed ID: 16682211
[TBL] [Abstract][Full Text] [Related]
6. Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.
Guo HX; Wang F; Yu KQ; Chen J; Bai DL; Chen KX; Shen X; Jiang HL
Acta Pharmacol Sin; 2005 Oct; 26(10):1201-11. PubMed ID: 16174436
[TBL] [Abstract][Full Text] [Related]
7. Peptidyl-prolyl isomerase inhibitors.
Wang XJ; Etzkorn FA
Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
[TBL] [Abstract][Full Text] [Related]
8. The three-dimensional structure of two redox states of cyclophilin A from Schistosoma mansoni. Evidence for redox regulation of peptidyl-prolyl cis-trans isomerase activity.
Gourlay LJ; Angelucci F; Baiocco P; Boumis G; Brunori M; Bellelli A; Miele AE
J Biol Chem; 2007 Aug; 282(34):24851-7. PubMed ID: 17591771
[TBL] [Abstract][Full Text] [Related]
9. [Design, synthesis and biological evaluation of novel diaryl ethers bearing a pyrimidine motif as human Pin1 inhibitors].
Xi YY; Jin J; Sun Y; Chen XG; Song HR; Xu BL
Yao Xue Xue Bao; 2013 Aug; 48(8):1266-72. PubMed ID: 24187834
[TBL] [Abstract][Full Text] [Related]
10. A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.
Mori T; Hidaka M; Lin YC; Yoshizawa I; Okabe T; Egashira S; Kojima H; Nagano T; Koketsu M; Takamiya M; Uchida T
Biochem Biophys Res Commun; 2011 Mar; 406(3):439-43. PubMed ID: 21333629
[TBL] [Abstract][Full Text] [Related]
11. The microtubule-targeting agents, PBOX-6 [pyrrolobenzoxazepine 7-[(dimethylcarbamoyl)oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine] and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and pin1, in malignant hematopoietic cells.
Bane FT; Bannon JH; Pennington SR; Campiani G; Williams DC; Zisterer DM; Mc Gee MM
J Pharmacol Exp Ther; 2009 Apr; 329(1):38-47. PubMed ID: 19131583
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of peptidyl-prolyl cis/trans isomerase activity by substrate analog structures: thioxo tetrapeptide-4-nitroanilides.
Schutkowski M; Wöllner S; Fischer G
Biochemistry; 1995 Oct; 34(40):13016-26. PubMed ID: 7548060
[TBL] [Abstract][Full Text] [Related]
13. Aryl hetaryl ketones and thioketones as efficient inhibitors of peptidyl-prolyl cis-trans isomerases.
Hediger T; Frank W; Schumann M; Fischer G; Braun M
Chem Biodivers; 2012 Nov; 9(11):2618-34. PubMed ID: 23161639
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design of novel human Pin1 inhibitors (I).
Guo C; Hou X; Dong L; Dagostino E; Greasley S; Ferre R; Marakovits J; Johnson MC; Matthews D; Mroczkowski B; Parge H; Vanarsdale T; Popoff I; Piraino J; Margosiak S; Thomson J; Los G; Murray BW
Bioorg Med Chem Lett; 2009 Oct; 19(19):5613-6. PubMed ID: 19729306
[TBL] [Abstract][Full Text] [Related]
15. Convergent synthesis of alpha-ketoamide inhibitors of Pin1.
Xu GG; Etzkorn FA
Org Lett; 2010 Feb; 12(4):696-9. PubMed ID: 20102178
[TBL] [Abstract][Full Text] [Related]
16. Oligopeptide cyclophilin inhibitors: a reassessment.
Schumann M; Jahreis G; Kahlert V; Lücke C; Fischer G
Eur J Med Chem; 2011 Nov; 46(11):5556-61. PubMed ID: 21963115
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.
Zhu L; Jin J; Liu C; Zhang C; Sun Y; Guo Y; Fu D; Chen X; Xu B
Bioorg Med Chem; 2011 May; 19(9):2797-807. PubMed ID: 21504850
[TBL] [Abstract][Full Text] [Related]
18. Cyclosporins: lack of correlation between antischistosomal properties and inhibition of cyclophilin isomerase activity.
Khattab A; Pica-Mattoccia L; Klinkert MQ; Wenger R; Cioli D
Exp Parasitol; 1998 Sep; 90(1):103-9. PubMed ID: 9709036
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the cyclosporin A/cyclophilin complex by NMR.
Thériault Y; Logan TM; Meadows R; Yu L; Olejniczak ET; Holzman TF; Simmer RL; Fesik SW
Nature; 1993 Jan; 361(6407):88-91. PubMed ID: 8421500
[TBL] [Abstract][Full Text] [Related]
20. Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
Potter AJ; Ray S; Gueritz L; Nunns CL; Bryant CJ; Scrace SF; Matassova N; Baker L; Dokurno P; Robinson DA; Surgenor AE; Davis B; Murray JB; Richardson CM; Moore JD
Bioorg Med Chem Lett; 2010 Jan; 20(2):586-90. PubMed ID: 19969456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
